Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The European clinical chemistry market estimated to grow at a CAGR of 3.8% from 2018 to 2024. High government participation in the form of health insurance, increasing medical need for aging population and rising patients of diabetes, high cholesterol, high blood pressure and lung and heart diseases is driving the market for clinical chemistry in Europe. Along with this, large number of manufacturers and high importance to innovations and advanced technologies in clinical chemistry and healthcare in general makes clinical chemistry analyzers a very lucrative market in this region. The European clinical chemistry analyzers market is divided into reagents and devices. The reagents market is further divided into metabolites, enzymes, electrolytes and others. The metabolites market dominate the American clinical chemistry analyzers market with a market share of 43.0% in 2015. The devices market is majorly studied for semi- automatic devices and fully automatic devices. The market is dominated by fully automatic clinical chemistry devices such as entry level, medium throughput analyzers, high throughput and high throughput modular analyzers. The market for high throughput modular analyzers is the highest due to easy usage and accurate results facilitated by options of performing multiple tests. The clinical chemistry analyzers are majorly used in hospitals, diagnostic laboratories, academic institutes and others such as blood banks, cancer research centers, military hospitals among others. The usage of different types of clinical chemistry analyzers is highly done in hospitals followed by diagnostic laboratories and academic institutions. The major countries considered in the European clinical chemistry analyzers market are Germany, France, Italy, U.K., Spain and others which include Turkey, Russia, Sweden among others. Germany dominates the market with a market share of 20.9% in 2015. The market dominance is mainly due to well established healthcare systems, in terms of infrastructure, hospitals and medical professionals along with advanced and modernized clinical chemistry analyzers. The leading players in this industry include Siemens, Human Diagnostics, Greiner Diagnostic, Randox Laboratories Led., Cambridge Life Sciences Ltd., Bexter Healthcare, GE Healthcare among others. These companies have established their position in the market by offering competent products. Along with this, they are making their presence strong in the market though strategies such as mergers, acquisitions, joint ventures and collaborations.
Why to buy this report:
